公司概覽
業務類別 Biotechnology
業務概覽 Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.
公司地址 150 North Radnor Chester Road, Suite F200, Radnor, PA, USA, 19087
電話號碼 +1 888 378-6240
傳真號碼 --
公司網頁 https://mineralystx.com
員工數量 76
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Jon Congleton President, Chief Executive Officer and Director 美元 636.50K 08/04/2026
Mr. Adam S. Levy Chief Financial Officer, Principal Accounting Officer and Secretary 美元 532.00K 12/03/2026
Mr. Eric Warren, R.Ph. Chief Commercial Officer -- 12/03/2026
Mr. James J. Ferguson, III,M.D. Chief Medical Officer -- 11/08/2026
 
董事會成員
董事會 職務 更新日期
Mr. Glenn P. Sblendorio Chairman of the Board 08/04/2026
Dr. Srinivas Akkaraju, M.D.,PhD Independent Director 08/04/2026
Ms. Kristine Peterson Independent Director 19/10/2026
Mr. Lonnel Coats Independent Director 19/10/2026
Mr. Jon Congleton President, Chief Executive Officer and Director 08/04/2026
Dr. Derek DiRocco, PhD Independent Director 04/11/2026
Ms. Daphne Karydas, M.B.A. Independent Director 08/04/2026
Dr. Brian Taylor Slingsby, M.D.,PhD Independent Director 08/04/2026
Dr. Alexander M. Gold, M.D. Independent Director 08/04/2026
 
所屬ETF (更新日期: 14/11/2026 02:45)
代號 名稱 佔比% ▼ 持有日期
RUSCRussell Inv U.S. Small Cap Equity ETF<0.000001%22/09/2026
STXKStrive Small-Cap ETF<0.000001%10/09/2026
VFMOVanguard US Momentum Factor ETF<0.000001%30/09/2026
  1    2    3   4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.